Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Research, development and commercialization of its novel gene and cell therapies and vaccines4.06M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States4.06M100.00%